NO20065681L - 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater - Google Patents
4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivaterInfo
- Publication number
- NO20065681L NO20065681L NO20065681A NO20065681A NO20065681L NO 20065681 L NO20065681 L NO 20065681L NO 20065681 A NO20065681 A NO 20065681A NO 20065681 A NO20065681 A NO 20065681A NO 20065681 L NO20065681 L NO 20065681L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- piperazinyl
- piperidinyl
- rog
- bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse omhandler substituerte 4-fenyl-l-piperazinyl derivater som har formelen I, hvori W er C, CH eller N, og den stiplede linjen som utgår fra W indikerer en binding når W er C og ingen binding når W er N eller CH;. Rog Rvelges uavhengig fra hydrogen og halogen, forutsatt at minst én av Rog Rer et halogenatom; X er CH, O, S, CO, CS, SO eller S0; og. Q er en gruppe med formel (II),. forutsatt at X ikke er O eller S når gruppen Q er forbundet via et N atom;. og enhver av dens enantiomerer og syreaddisjonssalter derav.Disse forbindelsene har høy affinitet for Dreseptorer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199901887 | 1999-12-30 | ||
| PCT/DK2000/000728 WO2001049679A1 (en) | 1999-12-30 | 2000-12-22 | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065681L true NO20065681L (no) | 2002-08-02 |
Family
ID=8108820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023151A NO323401B1 (no) | 1999-12-30 | 2002-06-28 | Halogensubstituerte 4-fenyl-piperazinderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse. |
| NO20065681A NO20065681L (no) | 1999-12-30 | 2006-12-14 | 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023151A NO323401B1 (no) | 1999-12-30 | 2002-06-28 | Halogensubstituerte 4-fenyl-piperazinderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse. |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US7074796B2 (no) |
| EP (2) | EP1464641B1 (no) |
| JP (1) | JP2003519225A (no) |
| KR (2) | KR100792186B1 (no) |
| CN (2) | CN1803784A (no) |
| AR (1) | AR029461A1 (no) |
| AT (2) | ATE269857T1 (no) |
| AU (2) | AU783786B2 (no) |
| BG (1) | BG106960A (no) |
| BR (1) | BR0016953A (no) |
| CA (1) | CA2395869C (no) |
| CZ (1) | CZ20022603A3 (no) |
| DE (2) | DE60011817T2 (no) |
| DK (2) | DK1464641T3 (no) |
| EA (2) | EA008627B1 (no) |
| ES (2) | ES2302992T3 (no) |
| HK (1) | HK1055960A1 (no) |
| HR (1) | HRP20020567A2 (no) |
| HU (1) | HUP0203839A3 (no) |
| IL (3) | IL150366A0 (no) |
| IS (1) | IS6432A (no) |
| MX (1) | MXPA02006590A (no) |
| NO (2) | NO323401B1 (no) |
| NZ (2) | NZ530137A (no) |
| PL (1) | PL355502A1 (no) |
| PT (2) | PT1464641E (no) |
| SG (1) | SG152900A1 (no) |
| SK (1) | SK11072002A3 (no) |
| TR (2) | TR200402408T4 (no) |
| UA (1) | UA73756C2 (no) |
| WO (1) | WO2001049679A1 (no) |
| ZA (1) | ZA200205019B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE402704T1 (de) * | 2000-03-27 | 2008-08-15 | Abbott Gmbh & Co Kg | Dopamin-d3-rezeptor-liganden zur behandlung von sucht |
| GB0117577D0 (en) * | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
| FR2831166B1 (fr) * | 2001-10-18 | 2004-02-27 | Sanofi Synthelabo | Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant |
| US7550459B2 (en) | 2001-12-28 | 2009-06-23 | Acadia Pharmaceuticals, Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
| EP1461318B9 (en) | 2001-12-28 | 2005-12-28 | Acadia Pharmaceuticals Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
| ES2303960T3 (es) * | 2003-12-23 | 2008-09-01 | H. Lundbeck A/S | Derivados de 2-(1h-indolilsulfanil)-bencilamina como isrs. |
| DE102004027358A1 (de) * | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
| AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| FR2878524B1 (fr) * | 2004-12-01 | 2007-01-19 | Bioprojet Soc Civ Ile | Nouveaux derives d'arylpiperazine |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| US9598401B2 (en) | 2013-07-29 | 2017-03-21 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
| EP3083589B1 (en) | 2013-12-20 | 2019-12-18 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use thereof |
| US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB944443A (no) * | 1959-09-25 | 1900-01-01 | ||
| US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
| DE2138865A1 (de) * | 1970-08-15 | 1973-02-22 | Sumitomo Chemical Co | 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel |
| FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
| US4950664A (en) * | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
| DE4101686A1 (de) | 1991-01-22 | 1992-07-23 | Merck Patent Gmbh | Indolderivate |
| US5556857A (en) * | 1991-05-08 | 1996-09-17 | Otsuka Pharmaceutical Co., Ltd. | Disturbance-of-consciousness improving agent |
| IT1255178B (it) * | 1992-06-26 | 1995-10-20 | Pierrel Spa | N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica |
| US5814644A (en) * | 1993-04-15 | 1998-09-29 | Merck Sharp & Dohme, Ltd. | Indole derivatives as dopamine D4 antagonists |
| DE69434872T2 (de) * | 1993-06-28 | 2007-04-05 | Wyeth | Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten |
| JPH10510253A (ja) * | 1994-12-07 | 1998-10-06 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | ウラシル誘導体 |
| WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
| AU8457298A (en) * | 1997-08-15 | 1999-03-08 | Pfizer Products Inc. | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor |
| US6355644B1 (en) * | 1999-06-14 | 2002-03-12 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
| US6376514B1 (en) * | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| TW580446B (en) * | 2003-05-15 | 2004-03-21 | Benq Corp | Color electrode array printer |
-
2000
- 2000-12-22 DK DK04007739T patent/DK1464641T3/da active
- 2000-12-22 PT PT04007739T patent/PT1464641E/pt unknown
- 2000-12-22 CN CNA2005101310970A patent/CN1803784A/zh active Pending
- 2000-12-22 TR TR2004/02408T patent/TR200402408T4/xx unknown
- 2000-12-22 NZ NZ530137A patent/NZ530137A/en unknown
- 2000-12-22 CA CA002395869A patent/CA2395869C/en not_active Expired - Fee Related
- 2000-12-22 CZ CZ20022603A patent/CZ20022603A3/cs unknown
- 2000-12-22 EP EP04007739A patent/EP1464641B1/en not_active Expired - Lifetime
- 2000-12-22 PL PL00355502A patent/PL355502A1/xx not_active IP Right Cessation
- 2000-12-22 NZ NZ519740A patent/NZ519740A/en unknown
- 2000-12-22 KR KR1020077000879A patent/KR100792186B1/ko not_active IP Right Cessation
- 2000-12-22 SK SK1107-2002A patent/SK11072002A3/sk unknown
- 2000-12-22 KR KR1020027008576A patent/KR100729536B1/ko not_active IP Right Cessation
- 2000-12-22 EA EA200400641A patent/EA008627B1/ru not_active IP Right Cessation
- 2000-12-22 AT AT00984931T patent/ATE269857T1/de not_active IP Right Cessation
- 2000-12-22 DE DE60011817T patent/DE60011817T2/de not_active Expired - Fee Related
- 2000-12-22 JP JP2001550219A patent/JP2003519225A/ja active Pending
- 2000-12-22 BR BR0016953-6A patent/BR0016953A/pt not_active Application Discontinuation
- 2000-12-22 WO PCT/DK2000/000728 patent/WO2001049679A1/en active Application Filing
- 2000-12-22 IL IL15036600A patent/IL150366A0/xx active IP Right Grant
- 2000-12-22 ES ES04007739T patent/ES2302992T3/es not_active Expired - Lifetime
- 2000-12-22 UA UA2002065264A patent/UA73756C2/uk unknown
- 2000-12-22 SG SG200405552-1A patent/SG152900A1/en unknown
- 2000-12-22 ES ES00984931T patent/ES2223628T3/es not_active Expired - Lifetime
- 2000-12-22 HU HU0203839A patent/HUP0203839A3/hu unknown
- 2000-12-22 DK DK00984931T patent/DK1246817T3/da active
- 2000-12-22 MX MXPA02006590A patent/MXPA02006590A/es active IP Right Grant
- 2000-12-22 AU AU21527/01A patent/AU783786B2/en not_active Ceased
- 2000-12-22 PT PT00984931T patent/PT1246817E/pt unknown
- 2000-12-22 EP EP00984931A patent/EP1246817B1/en not_active Expired - Lifetime
- 2000-12-22 CN CNB00819145XA patent/CN1244577C/zh not_active Expired - Fee Related
- 2000-12-22 AT AT04007739T patent/ATE395333T1/de not_active IP Right Cessation
- 2000-12-22 TR TR2002/01690T patent/TR200201690T2/xx unknown
- 2000-12-22 EA EA200200729A patent/EA005013B1/ru not_active IP Right Cessation
- 2000-12-22 DE DE60038911T patent/DE60038911D1/de not_active Expired - Fee Related
- 2000-12-28 AR ARP000106991A patent/AR029461A1/es not_active Application Discontinuation
-
2002
- 2002-06-19 IS IS6432A patent/IS6432A/is unknown
- 2002-06-21 ZA ZA200205019A patent/ZA200205019B/en unknown
- 2002-06-23 IL IL150366A patent/IL150366A/en not_active IP Right Cessation
- 2002-06-27 US US10/186,339 patent/US7074796B2/en not_active Expired - Fee Related
- 2002-06-28 NO NO20023151A patent/NO323401B1/no unknown
- 2002-07-03 HR HR20020567A patent/HRP20020567A2/hr not_active Application Discontinuation
- 2002-07-26 BG BG106960A patent/BG106960A/bg unknown
-
2003
- 2003-11-13 HK HK03108252A patent/HK1055960A1/xx unknown
-
2006
- 2006-03-08 AU AU2006201000A patent/AU2006201000A1/en not_active Abandoned
- 2006-03-15 US US11/377,772 patent/US7223765B2/en not_active Expired - Fee Related
- 2006-12-14 NO NO20065681A patent/NO20065681L/no not_active Application Discontinuation
-
2007
- 2007-10-25 IL IL186954A patent/IL186954A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065681L (no) | 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater | |
| NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
| NO20073720L (no) | Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer | |
| TW369533B (en) | Quinoline compounds, process for preparing them and pharmaceutical composition containing them | |
| NO20092380L (no) | Amino-nikotin- og isonikotinsyrederivater anvendelige som DHODH-inhibitorer | |
| ATE368656T1 (de) | Piperidinderivate zur verwendung bei der behandlung von durch chemokins vermittelten leiden | |
| NO20063501L (no) | Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese | |
| SE8503888D0 (sv) | Heterocykliska derivat | |
| EA200500852A1 (ru) | Промежуточные соединения для синтеза производных цианопирролидина | |
| NO20031731L (no) | Nitrogenholdige aromatiske ringforbindelser | |
| NO20025641L (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| NO20045331L (no) | Piperazinylacylpiperidinderivater, deres fremstilling og terapeutisk anvendelse derav | |
| NO20062936L (no) | Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav | |
| NO20055695L (no) | Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer | |
| NO972887L (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
| NO20032291L (no) | Pyrimidinderivater | |
| DK1335913T3 (da) | Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf | |
| DE60329189D1 (de) | Pyrrolidinderivate als oxytocin antagonisten | |
| DK0579059T3 (da) | Pyridazinonderivater og fremgangsmåder til fremstilling af samme | |
| DK1165543T3 (da) | Fremgangsmåde til fremstilling af [S-(R*,S*)]-G(B)-[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinpropansyre og derivater deraf | |
| JO2615B1 (en) | Benzimidazole compound | |
| DK193090A (da) | Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf | |
| ATE249459T1 (de) | N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| ES8300707A1 (es) | Procedimiento para preparar derivados del acido nicotinico. | |
| DE60209517D1 (de) | Pharmazeutisch geeignete salze von 20(s)-camptothecinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |